Menu
GeneBe

AP5Z1

adaptor related protein complex 5 subunit zeta 1, the group of Armadillo like helical domain containing|Adaptor related protein complex 5

Basic information

Region (hg38): 7:4775614-4794397

Previous symbols: [ "KIAA0415" ]

Links

ENSG00000242802NCBI:9907OMIM:613653HGNC:22197Uniprot:O43299AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • hereditary spastic paraplegia 48 (Moderate), mode of inheritance: AR
  • hereditary spastic paraplegia 48 (Moderate), mode of inheritance: AR
  • hereditary spastic paraplegia 48 (Strong), mode of inheritance: AR
  • hereditary spastic paraplegia 48 (Supportive), mode of inheritance: AR
  • hereditary spastic paraplegia (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Spastic paraplegia 48, autosomal recessiveARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingNeurologic20613862; 22554690

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the AP5Z1 gene.

  • Hereditary spastic paraplegia 48 (763 variants)
  • not provided (275 variants)
  • Hereditary spastic paraplegia (107 variants)
  • Inborn genetic diseases (82 variants)
  • not specified (38 variants)
  • Spastic Paraplegia, Recessive (4 variants)
  • AP5Z1-related condition (1 variants)
  • High myopia (1 variants)
  • Spastic paraplegia (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the AP5Z1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
13
clinvar
140
clinvar
11
clinvar
164
missense
312
clinvar
8
clinvar
2
clinvar
322
nonsense
9
clinvar
6
clinvar
15
start loss
0
frameshift
6
clinvar
5
clinvar
5
clinvar
16
inframe indel
9
clinvar
1
clinvar
1
clinvar
11
splice donor/acceptor (+/-2bp)
1
clinvar
8
clinvar
9
splice region
1
17
21
3
42
non coding
121
clinvar
122
clinvar
72
clinvar
315
Total 16 19 460 271 86

Highest pathogenic variant AF is 0.0000920

Variants in AP5Z1

This is a list of pathogenic ClinVar variants found in the AP5Z1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
7-4775648-G-T Hereditary spastic paraplegia 48 Uncertain significance (Jan 13, 2018)360303
7-4775690-C-T Hereditary spastic paraplegia 48 Uncertain significance (Jan 13, 2018)910638
7-4775713-G-A Hereditary spastic paraplegia 48 • Hereditary spastic paraplegia • AP5Z1-related disorder Benign/Likely benign (Aug 09, 2022)360304
7-4775715-G-C Hereditary spastic paraplegia 48 • Hereditary spastic paraplegia Likely benign (Oct 10, 2023)585436
7-4775723-C-T Hereditary spastic paraplegia 48 Uncertain significance (Sep 22, 2022)1428396
7-4775737-A-C Hereditary spastic paraplegia 48 Uncertain significance (Jan 01, 2019)842736
7-4775748-C-T AP5Z1-related disorder Likely benign (Nov 14, 2019)3045996
7-4775752-G-C Uncertain significance (Feb 10, 2021)1256232
7-4775760-CGG-C Hereditary spastic paraplegia 48 Likely benign (Apr 28, 2023)2141185
7-4775761-G-T Hereditary spastic paraplegia 48 Uncertain significance (Jan 22, 2024)1945171
7-4775765-G-A Hereditary spastic paraplegia 48 Likely benign (Aug 08, 2022)2164278
7-4775771-C-T Hereditary spastic paraplegia 48 Likely benign (Dec 06, 2023)2068699
7-4775772-G-A Hereditary spastic paraplegia 48 Benign (Jan 28, 2024)1599917
7-4775775-C-T Hereditary spastic paraplegia 48 Likely benign (Dec 11, 2023)1988936
7-4775897-T-G Benign (Jul 27, 2018)1244760
7-4775972-T-C Benign (Jul 27, 2018)1276003
7-4775988-T-G Likely benign (Sep 12, 2019)1214029
7-4776041-C-G Benign (Jun 19, 2019)1252686
7-4776567-AAAAAAAAAAAAAAAAAAATTAGCCGGGCGTGGTGGTGGGTGACTGTAATCCCAGCTACTCGGGAGGCTGAGGCAGGAGGATTGCTTGAACCTGTGAGGTGGAGGTTACAGTGAGCTGAGATGGCGCCACTGCACTCCAGGCTGGGGGACAGAGCGAAACTCCGTCTCAAAAGAAAAAAGAAAAAAAGTAAAGAAAATACAGCCAGCACTACAGCCCCTTGGTAAACGTAAACAAACTTGGTGAGGTGAGAGGCCGAAGCAGGAGAAGTGCATGAACCCAGGAGGCCGAGGGTGCAGTGAGCCAAGATCGCACCACTGGACTCCAGTCTGGGTGACAGAACGAGACTCCATGTCAAAACAAACAAGCAAACCTGGACTCAGAGCTAGACCAATTGGTGGGAAAGATTCGGGTGGTTGAAATTGCTGTGATTATAGTGAGTGAGGTCTTGAAGGCAGGTTAAGTTCTAAAGCCCGAACAGGACAAAAATCTCTGATCAAAATAACCCTTAAGAGTCCACTCATTAGGAAGAGGCTTGGTGAATATGCAGCACCATCTCCCAGCAGCTCAACATAGGCAACCTTCCCTTCAATCCTGGACAGATATGTCATTCATGTGAATGTGGGGACTATATGAAAATGAAAAATACTGGCATCTCAGCATGTAACATGTTAATCCCAAGGTCCTTGCCAAGAGACAAGGAAAAACACCCACTGAGAACTTCATTCCCAGTCACATTCTGCTCAAGGTCATAAACTTGTGACATGAAAAACAAAAGGAAGAGCCCTCTTTATTTATTTATTTATTTATTTATTTATTTATTTTTATTAGAGTCTCTTTTGAGACAGAGTCTCCCTCTGTCGCCCAGGCTGGAGTACAATGGCGCAATCTCAGTTCACTGCAACCTCCGCCTCCTGGGTTCAAGCAATTCTCCTGCCTCAGCCTCCCAAGTAGCTGGGATTACAGGCGCCCGCCACCACACCCGGCTGATTTTTTGTATCTTTAGTAGAGATGGGATTTCACCACATTGTCCAGGCTGGTCTCGAATTCCTGACCTCAGGTGATCCGCCTGACTCGGCCCCTCGAAGTGCCGGGATTACAGGTGTGAGCCACCATACCCGGCTGAGCCCTCACTATTTAAATACCTGTTTCTCTGCCTCCCTGGCTCGGGTGGGCAGCCGTTTTTGAGGATAGAGTGTGGTTGAATTTCCCTATGTAACATACATGAGTTCTGCAGTTGCCCTCTGTTAGGGTTTCAAGAAGGTTAATCTATTAGGGCTTACCAGTTTTCACAATATTCTTAAGCCTGTGATTTCTGATGATATTTTAAAATAAATGACTGTAGTTTGAGGGTTAAGGTTTGGAGCCGGCCAGGCGCAGTGACTGGCCCACGCCTGTAATCCGAACACTTCGGGAGGCCGAGTTAGGAGGATCGCTTGAGGCTAGGACTTTGAGACCAGCCTGGACAACATAGCGAGACCCGTCTCTACAAAACAGAATTTTTAAAAAACTTAGCCAGGTGTGGTGGCACGTACCCATAGTCACAGCTACTCAGGAGGCTGAGGCAGGAGGATCACTTGAGCCAAGGAGGTTGAGGCTGCGGTAAGCTATGATGGTGCCACTGCACTCCAGCTCGGGTGACAGAGGGAGACCCTGTCTCCAAAGAAAGCCAAAAAGATTTGGAGTGAACTTTAGTTTCTCTCTAAATGTGTCAGAGATACGGAAAGCAAGGGTGCAAAAAGTGATCAAAGATAGCGCTGCAAGCTGAAGGATAAATGGAGAGAGCGGGAAGCGAGTAAAGGATGGGGGCATGGAGGGGTGCCCCGCAAGGTCGGGGATTTCCAGGAGGAAGAGCCTCAGCCCACTAGCTCGGGAGCTAGTGGGGCATGTATCAGGCACAGGGTCTGTGCGAAGGGACAGAAGCAAAAGAAACAGGACATGGAGTCTGGAGAAGGAAGGCGGGGCCGGGCTCTTGGAGGCAGCGTTGGGGTCTGTAGGAGTTTGGATTTGAAAGCAGTGGGGAGCTGTTGAAGGGTTTGGGTGGGTTGGATTTTAGAGAGAAGCTTGAGACTTGGAGAATATGCTGAAGGGAATTTAATCGGGATGAGGGGTTCCACCTTTCTGGGAAAGATTTTCCATTGTGTGTATATATGTATATGTGTGTATATATAATTTATATATAACATTTTATATATTATATATTACATATATATTTAGTAATATATAATATAATTATATGTTATATATTATATGTTATATTATATATCATTATATATAATATATAATGATATATAATATTTTATATATAATCAAAAAAAGAATAAAAAAAATTCACTGGGCTTAGTGTAGTCCCAGCTACTTGAAAGGCTGAGGTGGGAGAACTGCTTGAGCTAGAAGATCAGGCTGCAGTGAGCTGAGATTATGCCACTGCACTCCAGCCTGGGTGACAGCATAAGACTCTATCTCAAAAAATATATATATAGATAGATAGATAGATATAAAAATATATTTTTATATGTAATATATATAAAATATATATTATATACATTTTTGAGATAGAGCATATTATATATTATATATAACATATATAACAACTATATAACATATATAACATAACATATATAACAACATAATATATAGCATATATTATGTATAACATATATTAGATATAACATATATAACATTAGAAATAATGTATATAACATAACATAACGTATATAACGCATATAACAACATATATAACGTATATAACATAACACGTTATATATGATATATAACATATAACATGTTATATATCATAACGTGTTATATGTCATATAACATGATTATTATATATCATATATAACATGATAACATATATATCATATATAACATATATAACATTATATATAACATATATATTATATTATATATATATATTTTTTTTTGAAGTAGAGTCTTACTCTGTCACCCAGGCTGGAGTGCAGTGGCACAATCTCAGCTCACTGCAGCCTGATCTTCCAGCTCAAGCAGTTCTCCCACCTCAGCCTTTCAAGTGGCTGGGACTACACCATGCCCAGTGAATTTTTTTTATTTTTATTTTTTTTTGTTTTTGAGACGGAGTTTTGCTCTCGTTGCCCAAGCTGGGGTGCAATGGCATGATCTCAGCTCACTGCAACCTCCTCCTCCCGGGTTCAAGTGATTCTCCTGCCTCAGCCTCCTGAGTAGCTGGGATTACAGGCTTGTGCCACCACGCCCAGCTATTTTTTTTTGTATTTTTAGTAGAAACGGGGTTTCTCCATGTTAGCCAGCTGGTCTTGAACTCCTGACCTCAGGTGATCAGCCCGCCTCGGCCTCCCAAAATGCTAGGATTACAGGTGTGAGCCACCGTGCGTGGCCGAATTTTTTTTATTCTTTTGTAGAGATGGGGTCTCACTGTTTTGCCCAGGATGGTCTCAGACATCTGCACTCAACTCATCCTCCCACCTCAGCGTCCCAAAGTGCTGGGATTACAGGTGGCCTGGGGAGGGCACAGCCACGTAGGGGGCCCTTCTCAGGGAGTCCCCAGAGTCCCCTGGCACAGCAACCCCTTTGCGCATTATTGGTTCTTTCTTTTAGACTGGGATAGAAACCTAAAAACAGGCTTCCATTTGGGACTTTTCAGTATCTTACCTGTGGCTTACTAGGGAGATTTTAAAATTAAGCCAATTAGTTATTCGAGTAAAAAAACATAATGGGCTTACCTTACAATATGTCATGACATTTGTTCTTTAATATATAAGATTTTATTCTCAGGCCAGGCGTGGTGGCTCACGCTTGTCATCCCAGCACTTTGGGAGGCCGAGGTGGGCAGATCATGAGGTCAGGAGTTTTGAGACCAGCCTGGCCAACATGGTGAAACCCCGTCTCTACTAAAAATGCAAAAATTAGCCGGGCGTAGGCCAGGCGCGGTGGCTCACGCCTGTAATCCCAGCACTTTGGGAGGCCGAGGTGGGCAGATCACGATGTCAGGAGATCAAGACCATCCTGGCCAACATGGTGAAACCCTGTCTTTACTAAAAAATACAAAAAAATTAGCCGGGCGTGGTGGTGGGTGCCTGTAATCCCATCTACTCGGAAGACTGAGGCAGGAGAATTGCTTGAACCCCGGAGGCGAAGGTTGCAGTGAGCCGAGATCATGACACTATATTCCAGCCCGGGTGACAGAGCAAGACTCCATCTCGGGGAAAAAAAAAATTTATTCTTGTTTCCATAAGCAAAAGGCTCATTGAAGACATCTTTTGAAAGGCACCTTATTCTAGAGTAAATTTCCTACTCTTGAATGAGACCCCTAAAAAGAATCGGTTTTAGTCCTTCTGCCCTGGGAACAAGAAAATCTAAGTGCATGGGGCCTCCGTGAGTGAGATTCGTCATAGTGCGCTGCAGCGATGGATCGGGAAATCCCAGGGTGAGAGGAACCAGCTCAGGGAATCAGCGAATTTATCTCGAGAGCCATGAGCCGTGGAACCGTGTTCCTCCACACACTCGGCTTCTCTTTTCTAAAGAGGGATTTTCCCTGCTCCAAGGGTTATCCTTTTTTTGGTTCCGAGCAGCGAGTGCTTCTGGGTCCTGAAGTCCTCTTCTTTGTTTAGGGAGATCCAGGACGAGGAGCTGAAGAAGTTCTGTTCCCGGATCTGTAAACTGCTGCAGGCGGAGGACTTGGGGCCGGACACCCTCGACTCCCTGCAGAGGCTCTTCCTCATCATCTCAGCCACGAAGTACAGCCGGAGGTGAGTGTGGCGACGGCTCAGGCCGGCTCCTCACACAGCGGCCCCAGGAGAACCCAGCCCACGCCCAGCAGGTCACTGCAGATGCTCCTTGGGGGTTGAGTCATTTGTCCACTTAAACCAGTGCTGAAGGTCCATCCTCATGTAAAATGCTCTGTCCACTGGCCCAAGGGTGCCCGGCCAGGTGCTCTGGGGCACCGGGTGCTCCTGCCACGGTCGTGACGTGTTACCGCCCACCACGGGCATCTCGCCTTCCAGGCTGGAGAAGACATGCGTAGACCTGCTGCAGGCCACCCTCGGCCTGCCTGCATGCCCCGAGCAGCTCCAGGTGCTTTGCGCCGCCATCCTGCGAGAGATGTCCCCCTCTGACAGCCTCAGCCTGGCCTGGGACCACACGCAGAACAGCCGGCAGCTGAGCCTGGTGGCCTCCGTTCTCTTGGCCCAGGTAGCGCAGCAGTCACCACCCCAGTTGGCACCGGATGGCTGCTTCCCAAGGAACAGGGGAGACAGGAAGCAGGGGCGCCAGAGCCGGCAGGTGGCTGCTTGTTGTAGACGCATCTCGGTGCTGAGTGCCTGGCACACTTGAGGCTGGGGCATGCCCTGTTGACTGGAACGGGGTCCCATGCCCAGCAGGCCCACGTGGTATGTTGGTGCTCAGGAGAGGTGGTGGAGTTTGGTTTCTCAGACAGAGCCTTGAGACAGCGAGTCAGTGGAGGCTGGGCCTCCAGACCTTCTTTTTGGGGTTTTTGTTTTGTTTTTTAGAAACAGGGTCTCACTCTGCTGTCCAGTGTAGAGTGCCATGGAGTGATCAATGCTCACTGCAGCCTCGACCTCCCTGGCTCAAGCAATCCTCCCATCTCAGCCTCCTGAGTAGCTGGGATTACAGGCATGCATCACCACACCCAGTTAATGTTTGTATTTTTTTGTAGGGACCTGGGGTCTCACTATGTTGCCCAGGCTGGTCTCAAACTTCTGGGCTCAAGCAATCCACCCTCCTTGGCCAGGAGTTTTTGCCAAGTCCATGTCCTCCCTCCCTCTGTGTCGGGAGCAGGCCTGGGCACTCAGCGTGGGGATCCAGGGGTTCACAGGCTGCCTTTGTGTGAGAGAAGCTGCTATCTCTGCTCATGGGTTGCCCAGGGGTGCAGAGTCTGCAGGAAGGTTGCGATGGAGCTGGGCTTTTCCCTCCGTTCCCAGCCTGCAGCGTCATGAGTTGCCTCCTGTGCTGGGGTGCAGCCTGCGGTTGCTTTAGTTCTGTGTGGGCGAGAGCTTGTGGGCCCCGGCGTACTCAGGGCGTTGTACTTCATCACTGGGGTCATCCTGGTTGGTGCCCAGCCCCCTCACCTCACAGACCTCCTGCAGGCCACCTCCAGGCCTCCGAGATGACCCCGGTAATGCTGTGGTAGCTCCTGGCCTTTGGAACAAGATGACTCCGGCTCTTCTTGTTTGTTTCACCCGCCCTTCTCCTCAAGCAACTCATTTTTTTCAGTGGAAGATGATCTTGCAGAACTGCTGCCAGGCGCCAGCGGTGCACCCCCCGCCCGGCACGTGGCCTCCCAGCCACCCAGCCGCCCTCCTCCCTGCCCTGACGGCCCTGCCCCTGTGCTGGGTGTCTCTGGTGCTGCTCAGATGTTTCAGCACCTGGGTGTGCAGAGTGAGGTGGGTGGTTTAAAGACTGGGATCCACACTGGAGGCCCCGCAGGACGGGGTGTCCTGTGTCTGCGGCCAGGGCCATGGTGGCCGCCAGTGTGTTTTTAGCATTGAATCAGCCGTGCCCTCACCCAGGCCCCCTCCAGCCTCAGCGATGCAGCTCCCAGGGAGAGAGGCTGGAGGCGGAGCAGGCACCTTGTGGCCCGGGGTGGGCCTGCGCGGGACATCCTCCCTGCCACCTGCTAGGCCGGGGTCTCAGCGACCGACGCTTCTCAGGAGTGTCACACAGACTTCCGAAATGGGGGAGCTGGTCTCTGGCACAGGCCAGTACCCCAGCGTTTGCCCTGTTTGATTTGAAGGGTGACAGAAACGAGGAGGTCAGAGCCGTGGGCCAGGGCGTGCTACGAGCGCTGGAGAGCCGGCAGCCTGAGGGACCCAGCCTCAGACACCTCCTCCCCGTCATGGCCAAGGTCGTGGTCCTCAGCCCGGGCACCCTCCAGGAGGGTACGCGGGGCCCCTCCCAAGAGGCTGTTGGGGGTCTGCCTTCCCAGGTCCTTCCCTGAGGGCCCATGGTGGGTTGGGAGTGTGGGGGGCAGGTGGGGGACACGGGGAGGCCCGAGGGTTTGGGACGCTGCAGGATTCTGTTTTCTGAGAAAAGTCGGCCAGCATCCCAACAACCCAGGCATCTGTAGGATTCAACCTCACCTCCCCATGCCACCCCACCCACTGCAGACCAGGCCACCCTGCTCAGCAAGCGGCTGGTCGACTGGCTGCGCTACGCCAGCCTCCAGCAAGGGCTCCCACACTCCGGCGGCTTCTTCTCCACGCCCAGGGCCCGGCAGGTGAGGCTGGGACTGTTCTGGAACCATGGGGAACAGAGTCACAGACAACCCCTCCCTGAGAGCTCCTGTGCCCACAGCGGCGAGGCCTGCTGTCGTTCCGCGGGGTCCAGGACGAGCCTGCCTCTGCTGCGGGGCTTGGGTCAGGCAGGGCCACAGCCCCCTGACCCGTGTGGCTCTGGGGGTCTGTGCGCGGGTTCAGTCCCAGGGCCTGCGGAGCAGGGTGTGCGACGCGCGTCTGCCTGGGGGTCAGGTGGGGATGGTGTTTTTGCATCACACAGGGCGGGCCGCTGCCCGGGCTCATGTTCAGGCAGCTTCTCCTCCACCTCCTGAGGAGCTTGTGCTAAAGGCTGGCGTTTTTCCCGGCCTCGGCCCCCTCCGCCCACTCCTGCCTGTCCTTCCCACAGCCGGGCCCCGTCACCGAGGTGGACGGGGCGGTAGCCACAGACTTCTTCACGGTGCTCTCCAGCGGCCACCGCTTCACAGACGACCAGTGGCTGAACGTGCAGGCCTTCTCTATGCTGCGGGCGTGGCTGCTGCACAGCGGCCCCGAGGGCCCGGGCACCCTGGACACAGGTGTGCGGGGTGGGGGGATGACGTCAGACAGGGGTGGGAGGTGGGCGCACTATGGGTTGGTCGCAGGGGGACACGGGCGGAGGTGGGGGGACTCGGGTGTGCCCAGGATGCAGCAGAGGTCAGGACTGAGCAACGCAGCCTGCTGACCTGGAGCTAGGCGGAGAGCACTCCCTGGCCAGCATCTTTGGGGTCCAGGGTCAGCACCGGGGATCCTCTGGACACCCCGTGACCCTCATGCAATGTGCAGATGTGAGAGCTCCCACTTAAGGCAGGCACCCTTAAGGTTGTTGGAGTGACGCCACTGAGCTCCTCCCGGCTGCTCTGTGGACTTGTTGGGGAAGAAGCCTCAGCCACCCTGAAGGGCGGCCGTGATGGGGAAGCTGCCGGGTGGGTGGACGTCCTGAGACGGTGACGCCTCACGCCTCCCGGGAGGGGCTGCGGCCTGTGCTCTCCTCCTGCCCTTCCAAGCAGGGCAGCAGGCATGTCCCAGCCCGGGAGCCACACGTCAGCCTGCTGAGAGTTCCCACCTCCCGCAGATGACAGGTCAGAGCAGGAGGGCTCCACTCTGTCGGTGATCTCCGCCACCTCCTCTGCCGGCCGCCTGCTGCCGCCCCGGGAGCGGCTTCGGGAGGTGGCCTTCGAGTACTGCCAGCGCCTCATTGAGCAAAGTAACCGACGTGAGTCCCCCACCCAGGGCACTGGCCTCCCCAGGGCTCGACGCACCTGCTCTGCAAGGCCACCTGAGGCCAGCACAGCTTCCCTGAGCTACTGCTCCACAGAGGGGGTCCCTGGGTAGCCGGTTTGGAGCAGGGGCATTTTTGCTTCTGGGGTCAGCCCCAAGTGTTCTTCAGGCTCCACCCCAGCCCCCAGCCCGGCCCTGTCCCACCTGGGCCCCTCGCCTCAGTCCCACTCAAGTCCTCCTGGGGGCCTGTCCCACCCCCCTGCTCCCGGTCCTGCCTGGAGCTTCCAGAGCACAAGCTGCCCCCTCATTGGGCCACTCTAAGGCTGAGACAGAGCCGGCTGACTTTTTCCCCTCCTTCCAGGAGCCCTGAGGAAGGGGGACTCCGACCTGCAGAAAGCTGTAAGTGGCTGGGGACCAGGGGATGGGAGGCAGCGACTCGGCCCATTTGATGTGGTCCATGTCCCGCAGT-A Hereditary spastic paraplegia 48 Likely pathogenic (Jun 13, 2018)579773
7-4780950-T-C Benign (Aug 15, 2018)1293085
7-4781029-C-T Likely benign (Apr 10, 2019)1178374
7-4781031-A-T Likely benign (Apr 10, 2019)1202338
7-4781098-C-T Likely benign (Jul 27, 2018)1207118
7-4781175-G-A Hereditary spastic paraplegia 48 Uncertain significance (Mar 11, 2019)855957
7-4781182-C-T Hereditary spastic paraplegia 48 Pathogenic (Nov 27, 2023)1458218

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
AP5Z1protein_codingprotein_codingENST00000348624 1718691
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
7.29e-310.0000060312456001851247450.000742
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-2.977005111.370.00003545064
Missense in Polyphen197132.741.48411313
Synonymous-7.624072531.610.00001911758
Loss of Function-0.7934337.71.140.00000216375

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.001460.00144
Ashkenazi Jewish0.0007140.000696
East Asian0.0009140.000890
Finnish0.0004440.000418
European (Non-Finnish)0.0009490.000920
Middle Eastern0.0009140.000890
South Asian0.0006260.000588
Other0.0001700.000165

dbNSFP

Source: dbNSFP

Function
FUNCTION: As part of AP-5, a probable fifth adaptor protein complex it may be involved in endosomal transport. According to PubMed:20613862 it is a putative helicase required for efficient homologous recombination DNA double-strand break repair. {ECO:0000269|PubMed:20613862, ECO:0000269|PubMed:22022230}.;
Disease
DISEASE: Spastic paraplegia 48, autosomal recessive (SPG48) [MIM:613647]: A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. {ECO:0000269|PubMed:20613862}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.102

Intolerance Scores

loftool
rvis_EVS
-0.6
rvis_percentile_EVS
17.52

Haploinsufficiency Scores

pHI
0.135
hipred
hipred_score
ghis
0.506

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.114

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Ap5z1
Phenotype

Gene ontology

Biological process
double-strand break repair via homologous recombination;protein transport;endosomal transport
Cellular component
nucleus;nucleoplasm;cytoplasm;nuclear speck;AP-type membrane coat adaptor complex;AP-5 adaptor complex
Molecular function
protein binding